Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

NASDAQ:MDB - Nasdaq - US60937P1066 - Common Stock - Currency: USD

273.26  -16.74 (-5.77%)

After market: 273 -0.26 (-0.1%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MDB. MDB was compared to 82 industry peers in the IT Services industry. While MDB seems to be doing ok healthwise, there are quite some concerns on its profitability. MDB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MDB was profitable.
MDB had a positive operating cash flow in the past year.
MDB had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MDB reported negative operating cash flow in multiple years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -6.21%, MDB is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
MDB has a Return On Equity (-13.34%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.21%
ROE -13.34%
ROIC N/A
ROA(3y)-10.67%
ROA(5y)-12.84%
ROE(3y)-36.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K 40K 60K 80K

1.3 Margins

With an excellent Gross Margin value of 73.86%, MDB belongs to the best of the industry, outperforming 91.03% of the companies in the same industry.
MDB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MDB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.22%
GM growth 5Y0.64%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MDB has been increased compared to 1 year ago.
Compared to 5 years ago, MDB has more shares outstanding
Compared to 1 year ago, MDB has an improved debt to assets ratio.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MDB has an Altman-Z score of 7.46. This indicates that MDB is financially healthy and has little risk of bankruptcy at the moment.
MDB has a Altman-Z score of 7.46. This is amongst the best in the industry. MDB outperforms 85.90% of its industry peers.
The Debt to FCF ratio of MDB is 7.87, which is on the high side as it means it would take MDB, 7.87 years of fcf income to pay off all of its debts.
MDB has a Debt to FCF ratio of 7.87. This is comparable to the rest of the industry: MDB outperforms 41.03% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MDB is not too dependend on debt financing.
MDB has a better Debt to Equity ratio (0.02) than 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 7.87
Altman-Z 7.46
ROIC/WACCN/A
WACC10.31%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MDB has a Current Ratio of 1.70. This is a normal value and indicates that MDB is financially healthy and should not expect problems in meeting its short term obligations.
MDB has a Current ratio (1.70) which is in line with its industry peers.
A Quick Ratio of 1.70 indicates that MDB should not have too much problems paying its short term obligations.
MDB has a Quick ratio of 1.70. This is comparable to the rest of the industry: MDB outperforms 57.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

MDB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.95%.
The Revenue has grown by 20.78% in the past year. This is a very strong growth!
MDB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.52% yearly.
EPS 1Y (TTM)6.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y41.79%
Revenue growth 5Y44.52%
Sales Q2Q%22.28%

3.2 Future

MDB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.62% yearly.
The Revenue is expected to grow by 18.44% on average over the next years. This is quite good.
EPS Next Y-7.35%
EPS Next 2Y1%
EPS Next 3Y9.35%
EPS Next 5Y19.62%
Revenue Next Year19.08%
Revenue Next 2Y18.35%
Revenue Next 3Y18.76%
Revenue Next 5Y18.44%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 84.60, the valuation of MDB can be described as expensive.
MDB's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.63, MDB is valued quite expensively.
With a Price/Forward Earnings ratio of 80.93, MDB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, MDB is valued quite expensively.
Industry RankSector Rank
PE 84.6
Fwd PE 80.93
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

MDB's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MDB is more expensive than 60.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 137.52
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1%
EPS Next 3Y9.35%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (2/21/2025, 8:00:01 PM)

After market: 273 -0.26 (-0.1%)

273.26

-16.74 (-5.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-09 2024-12-09/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners97%
Inst Owner Change-2.06%
Ins Owners0.77%
Ins Owner Change-1.31%
Market Cap20.35B
Analysts79.51
Price Target373.79 (36.79%)
Short Float %2.71%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.24%
Min EPS beat(2)40.33%
Max EPS beat(2)66.15%
EPS beat(4)4
Avg EPS beat(4)53.88%
Min EPS beat(4)27.24%
Max EPS beat(4)81.8%
EPS beat(8)8
Avg EPS beat(8)162.81%
EPS beat(12)12
Avg EPS beat(12)161.05%
EPS beat(16)16
Avg EPS beat(16)132.4%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)1.99%
Max Revenue beat(2)5.3%
Revenue beat(4)4
Avg Revenue beat(4)3.35%
Min Revenue beat(4)1.47%
Max Revenue beat(4)5.3%
Revenue beat(8)8
Avg Revenue beat(8)4.7%
Revenue beat(12)12
Avg Revenue beat(12)5.68%
Revenue beat(16)16
Avg Revenue beat(16)6.13%
PT rev (1m)-2.83%
PT rev (3m)9.02%
EPS NQ rev (1m)12.83%
EPS NQ rev (3m)-12.94%
EPS NY rev (1m)3.73%
EPS NY rev (3m)24.66%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 84.6
Fwd PE 80.93
P/S 10.62
P/FCF 137.52
P/OCF 131.9
P/B 13.55
P/tB 14.22
EV/EBITDA N/A
EPS(TTM)3.23
EY1.18%
EPS(NY)3.38
Fwd EY1.24%
FCF(TTM)1.99
FCFY0.73%
OCF(TTM)2.07
OCFY0.76%
SpS25.73
BVpS20.17
TBVpS19.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -13.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.86%
FCFM 7.72%
ROA(3y)-10.67%
ROA(5y)-12.84%
ROE(3y)-36.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.22%
GM growth 5Y0.64%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 7.87
Debt/EBITDA N/A
Cap/Depr 32.8%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z 7.46
F-Score5
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)36.1%
Cap/Depr(5y)38.88%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
EPS Next Y-7.35%
EPS Next 2Y1%
EPS Next 3Y9.35%
EPS Next 5Y19.62%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y41.79%
Revenue growth 5Y44.52%
Sales Q2Q%22.28%
Revenue Next Year19.08%
Revenue Next 2Y18.35%
Revenue Next 3Y18.76%
Revenue Next 5Y18.44%
EBIT growth 1Y-13.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.9%
EBIT Next 3Y22.38%
EBIT Next 5Y28.7%
FCF growth 1Y656.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1033.33%
OCF growth 3YN/A
OCF growth 5YN/A